NCT06429228

Brief Summary

Patients who undergo anterior vaginal wall plastic surgery and place the bladder catheter during surgery are selected. The purpose of the study is to evaluate the presence of statistically significant differences in bladder catheter repositioning within 12 hours after bladder catheter removal in the group of patients in whom the bladder catheter is removed on postoperative day I or II. Secondary outcomes include evaluation of the incidence of urinary tract infections, number of hospitalization days and total hospitalization costs for patients undergoing anterior vaginal wall surgery in patients in whom the bladder catheter is removed on postoperative day I or II.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2020

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

January 24, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 18, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 24, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

February 19, 2025

Status Verified

January 1, 2025

Enrollment Period

4 years

First QC Date

January 24, 2024

Last Update Submit

February 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • differences in bladder catheter repositioning within 12 hours after bladder catheter removal

    After removal of the bladder catheter, on postoperative day I or II, the appearance of urinary urge will be assessed and, in case of spontaneous urination, the quantity of urine will be measured. In the event that after the waiting time of 6 hours an adequate urination stimulus does not arise, we will proceed with an ultrasound evaluation of bladder stagnation (RV) and the application of the department protocol, as follows: * if the sum of diuresis and RV is between 500 and 1000 cc, extemporaneous catheterization and re-evaluation after 4 hours are indicated * if the sum of diuresis and RV is \> 1000cc, positioning of a bladder catheter and maintenance of the same for 5-7 days with subsequent evaluation is indicated.

    12 hours

Secondary Outcomes (1)

  • incidence of urinary tract infections for patients undergoing cystopexy surgery in patients in whom the bladder catheter is removed on postoperative day I or II.

    During hospital stay

Study Arms (2)

Catheter removal in postoperative day I

EXPERIMENTAL
Procedure: Catheter removal after surgery

Catheter removal in postoperative day II

EXPERIMENTAL
Procedure: Catheter removal after surgery

Interventions

Removal of catheter placed during the procedure in first or second post-surgical days.

Catheter removal in postoperative day ICatheter removal in postoperative day II

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women 18 years of age or older
  • Patients who are candidates for cystopexy surgery
  • Patients who have consented to the signing of the Informed Consent

You may not qualify if:

  • Micturition dysfunction with preoperative bladder stagnation \> 200 cc at pessary evaluation
  • History of recurrent cystitis
  • Positive preoperative urine culture
  • Azotemia \> 40 mg/dL or creatininemia \> 1 mg/dL
  • Not collected signed consent endorsed
  • Diabetes mellitus
  • Contraindications to transurethral bladder catheterization
  • Major protocol violations due to unforeseen intraoperative complications (bladder and/or rectal damage, severe bleeding with need for urinary monitoring)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS San Raffaele Hospital

Milan, 20132, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 24, 2024

First Posted

May 24, 2024

Study Start

April 20, 2020

Primary Completion

April 18, 2024

Study Completion

January 1, 2025

Last Updated

February 19, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations